192 related articles for article (PubMed ID: 32472310)
21. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
22. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
Varaklioti A; Kouramba A; Ioannidou P; Katsarou O
Infect Genet Evol; 2017 Oct; 54():397-401. PubMed ID: 28705716
[TBL] [Abstract][Full Text] [Related]
23. Anti-HBc-nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults.
Deng X; Guo X; Gu H; Wang D; Laperche S; Allain JP; Zang L; Candotti D
J Viral Hepat; 2022 Nov; 29(11):958-967. PubMed ID: 35876456
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
[TBL] [Abstract][Full Text] [Related]
25. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
26. Clearance of HBV DNA in immunized children born to HBsAg-positive mothers, years after being diagnosed with occult HBV infection.
Sadeghi A; Yahyapour Y; Poortahmasebi V; Shahmoradi S; Roggendorf M; Karimzadeh H; Alavian SM; Jazayeri SM
J Viral Hepat; 2016 Apr; 23(4):282-5. PubMed ID: 26598112
[TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study.
Yang YT; Huang AL; Zhao Y
Vaccine; 2019 Jan; 37(3):458-463. PubMed ID: 30527659
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China.
Wen X; Su H; Wang Y; Pu Z; Gao J; Ji Z; Yuan X; Li X; Zhang W; Zhang L; Long Y; Yan Y; Shao Z
J Viral Hepat; 2018 Mar; 25(3):281-288. PubMed ID: 29032635
[TBL] [Abstract][Full Text] [Related]
30. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
Vargas JI; Jensen D; Sarmiento V; Peirano F; Acuña P; Fuster F; Soto S; Ahumada R; Huilcaman M; Bruna M; Jensen W; Fuster F
J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.
Azarkar Z; Ziaee M; Ebrahimzadeh A; Sharifzadeh G; Javanmard D
J Med Virol; 2019 Apr; 91(4):615-622. PubMed ID: 30345529
[TBL] [Abstract][Full Text] [Related]
32. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.
Mu SC; Lin YM; Jow GM; Chen BF
J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923
[TBL] [Abstract][Full Text] [Related]
33. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
[TBL] [Abstract][Full Text] [Related]
34. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
35. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
[TBL] [Abstract][Full Text] [Related]
36. Occult hepatitis B virus infection: detection and significance.
Gerlich WH; Bremer C; Saniewski M; Schüttler CG; Wend UC; Willems WR; Glebe D
Dig Dis; 2010; 28(1):116-25. PubMed ID: 20460899
[TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults.
Salyani A; Shah J; Adam R; Otieno G; Mbugua E; Shah R
PLoS One; 2021; 16(1):e0244947. PubMed ID: 33406137
[TBL] [Abstract][Full Text] [Related]
38. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
39. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.
Bes M; Vargas V; Piron M; Casamitjana N; Esteban JI; Vilanova N; Pinacho A; Quer J; Puig L; Guardia J; Sauleda S
J Hepatol; 2012 Apr; 56(4):765-74. PubMed ID: 22173156
[TBL] [Abstract][Full Text] [Related]
40. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]